BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30

• Biotech Bay

  Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX

  Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced the submission of a new drug application (NDA) for chenodiol for the treatment of patients in the U.S. with cerebrotendinous xanthomatosis (CTX).

  June 28, 2024

   · 

  10 min read
• Biotech Beach

  Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy

  Capricor Therapeutics today announced additional positive 3-year safety and efficacy results from its ongoing HOPE-2 open label extension (OLE) study with its lead asset, deramiocel (CAP-1002), for the treatment of Duchenne muscular dystrophy (DMD).

  June 28, 2024

   · 

  9 min read
• Pharm Country

  Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology

  Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology.

  June 28, 2024

   · 

  4 min read
• Pharm Country

  Mitsubishi Tanabe Pharma America to Present Latest Parkinson’s Disease Research at the 10th Congress of the European Academy of Neurology

  Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations on investigational ND0612 in Parkinson’s disease (PD) will be shared at the 10th Congress of the European Academy of Neurology (EAN), being held in Helsinki, Finland, June 29 – July 2.

  June 28, 2024

   · 

  3 min read
• Deals

  Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds

  Cingulate Inc. today announced the entry into definitive agreements for the immediate exercise of certain outstanding Series A warrants to purchase up to an aggregate of 2,125,000 shares of common stock.

  June 28, 2024

   · 

  5 min read
• Press Releases

  NLS Pharmaceutics Announces Registered Direct Offering

  NLS Pharmaceutics Ltd. announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 3,277,750 of its common shares at a purchase price of $0.24 per share in a registered direct offering.

  June 28, 2024

   · 

  6 min read
• Genetown

  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders

  Oryzon Genomics, S.A. announced the voting results from its Annual General Meeting of Shareholders held in Madrid.

  June 28, 2024

   · 

  4 min read
• BioMidwest

  Epigenetic laboratory TruDiagnostic launches first ever organ-specific aging analysis from Yale-developed SYMPHONYAge algorithms

  Marking a milestone development in epigenetic research and clinical health applications, laboratory TruDiagnostic is launching the first ever, epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.

  June 28, 2024

   · 

  4 min read
• Pharm Country

  ECRI names Clinica Imbanaco winner of the 2024 Health Technology Excellence Award

  ECRI, a global independent healthcare and patient safety nonprofit, names Clinica Imbanaco the winner of its 2024 Health Technology Excellence Award.

  June 28, 2024

   · 

  4 min read
• BioCapital

  YorkTest Announces Limited–Time Offer to Enhance Accessibility of At-Home Health Testing

  YorkTest has launched a new offer to make at-home food sensitivity and allergy testing more accessible to households across the US.

  June 28, 2024

   · 

  2 min read